News

Article

Survey Reveals Impairment in Sexual Function Among Germ-Cell Tumor Survivors

Author(s):

Key Takeaways

  • Germ-cell tumors, often testicular, respond well to treatment but can lead to long-term sexual function impairments in survivors.
  • A study of 155 survivors showed those treated with chemotherapy and radiotherapy had more difficulty maintaining erections and achieving orgasms.
SHOW MORE

Germ cell tumors are growths that form from reproductive cells, which can be malignant or benign. In men, these tumors typically form in the testicles. The plus side is these tumors tend to respond well to treatment, even when diagnosed at later stages. However, one problem still persists after a cure.

Men reported sexual function impairments following treatment for their germ-cell tumors, especially those who received chemotherapy plus radiotherapy, according to study results presented at the 2018 Genitourinary Cancers Symposium.

Germ cell tumors are growths that form from reproductive cells, which can be malignant or benign. In men, these tumors typically form in the testicles. The plus side is these tumors tend to respond well to treatment, even when diagnosed at later stages. However, one problem still persists after a cure.

“Treatment for germ-cell tumors may lead to long-term consequences in germ-cell tumor survivors,” the researchers wrote. “This study aimed to evaluate a long-term sexual functioning after curative treatment for germ-cell tumors.”

Researchers identified 155 germ-cell tumor survivors from the National Cancer Institute in Bratislava, Slovakia. Patients completed a Sexual Function Questionnaire that was modified from PROMIS Sexual Function and Satisfaction Questionnaire at approximately 10 years of follow up.

Seventeen survivors who had orchiectomy served as the control group, while the remaining 138 survivors received treatment beyond orchiectomy, including cisplatin-based chemotherapy, radiotherapy to the retroperitoneal lymph nodes or both.

Survivors treated with both chemotherapy and radiotherapy, or any treatment, had difficulty maintaining an erection during intercourse compared with the control arm. Similarly, those treated with both chemotherapy and radiotherapy reported difficulty in achieving orgasm during intercourse and were disappointed with their overall quality of sex life.

However, survivors reported no differences in their sexual desire and in the number of attempts to initiate sexual intercourse in the month before follow-up. In addition, both groups reported none or mild anxiety resulting from sexual relationships, and the desire to be sexually active was moderate among all subgroups.

“Our prospective study shows that an impairment in sexual function is a significant issue for long-term germ-cell tumor survivors,” the researchers wrote. “Treatment with chemotherapy plus radiotherapy had the highest impact on the quality of sex life.”

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man
Image of smiling doctor.
Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Image of man with black hair.
Image of bald man.
Image of a man wearing a black suit and tie.
Image of a man with rectangular glasses and a goatee.
Image of a woman with a brown hair tied into a bun.
Related Content